Table 4 Linear mixed-effects model for the change in patient-reported outcomes.
Variables | Baseline values | Change from the baseline (mean and 95% confidence intervals) | |||
|---|---|---|---|---|---|
6 months | P value | 12 months | P value | ||
Number of symptoms in DSI | |||||
HDx | 12 (5–20) | − 2.0 (− 3.8 to − 0.3) | 0.024 | − 1.4 (− 3.3 to 0.5) | 0.140 |
Online-HDF | 11 (4–16) | − 0.5 (− 2.3 to 1.4) | 0.634 | − 1.0 (− 2.9 to 1.0) | 0.321 |
Between-group difference | − 1.6 (− 4.2 to 1.0) | 0.231 | − 0.4 (− 3.1 to 2.3) | 0.765 | |
Overall symptom severity score in DSI | |||||
HDx | 17 (10–37) | − 2.1 (–6.1 to 1.9) | 0.299 | − 2.7 (− 6.8 to 1.5) | 0.208 |
Online-HDF | 18 (6–27) | − 1.4 (–5.6 to 2.8) | 0.517 | − 1.3 (− 5.7 to 3.1) | 0.567 |
Between-group difference | − 0.7 (− 6.5 to 5.1) | 0.814 | − 1.4 (− 7.4 to 4.6) | 0.651 | |
Degree of fatigue after dialysis | |||||
HDx | 6 (5–7) | 0.1 (− 0.6 to 0.9) | 0.702 | − 0.6 (− 1.3 to 0.2) | 0.164 |
Online-HDF | 5 (3–6) | − 0.3 (− 1.1 to 0.5) | 0.513 | 0.1 (− 0.8 to 0.9) | 0.880 |
Between-group difference | 0.4 (− 0.7 to 1.5) | 0.459 | − 0.6 (− 1.8 to 0.5) | 0.287 | |
Recovery time after dialysis | |||||
HDx | 3 (2–3) | 0 (− 0.3 to 0.3) | 0.975 | 0 (− 0.3 to 0.4) | 0.786 |
Online-HDF | 2 (1–3) | − 0.1 (− 0.4 to 0.3) | 0.730 | − 0.1 (− 0.4 to 0.3) | 0.713 |
Between-group difference | 0 (− 0.4 to 0.5) | 0.912 | 0.1 (− 0.4 to 0.6) | 0.644 | |
